First Manhattan
TBPH icon

First Manhattan’s Theravance Biopharma TBPH Stock Holding History

First Manhattan’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-619,085
Closed -$16.9M – 1442
2018
Q2 		$14M Sell
619,085
-21,270
-3% -$505K 0.08% 148
2018
Q1 		$15.5M Sell
640,355
-813,812
-56% -$22.4M 0.09% 142
2017
Q4 		$40.6M Sell
1,454,167
-159,000
-10% -$4.71M 0.22% 76
2017
Q3 		$55.2M Sell
1,613,167
-141,433
-8% -$4.62M 0.32% 61
2017
Q2 		$69.9M Sell
1,754,600
-81,384
-4% -$3.13M 0.41% 46
2017
Q1 		$67.6M Sell
1,835,984
-5,471
-0.3% -$175K 0.4% 48
2016
Q4 		$58.7M Buy
1,841,455
+797,722
+76% +$24.7M 0.36% 50
2016
Q3 		$37.8M Buy
1,043,733
+22,500
+2% +$626K 0.23% 83
2016
Q2 		$23.2M Buy
1,021,233
+5,692
+0.6% +$123K 0.14% 110
2016
Q1 		$19.1M Sell
1,015,541
-41,751
-4% -$683K 0.12% 121
2015
Q4 		$17.3M Sell
1,057,292
-103,003
-9% -$1.63M 0.11% 126
2015
Q3 		$12.8M Sell
1,160,295
-12,294
-1% -$157K 0.08% 142
2015
Q2 		$15.3M Sell
1,172,589
-126,358
-10% -$1.96M 0.09% 137
2015
Q1 		$22.5M Sell
1,298,947
-148,013
-10% -$2.71M 0.13% 116
2014
Q4 		$21.6M Buy
1,446,960
+224,295
+18% +$3.91M 0.12% 119
2014
Q3 		$28.2M Buy
1,222,665
+921,933
+307% +$26.7M 0.16% 101
2014
Q2 		$9.59M Buy
+300,732
New +$9.05M 0.06% 175

Other funds holding TBPH

WIM
Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

First Manhattan's TBPH Position: Q3 2018 in Review

First Manhattan sold out of Theravance Biopharma (TBPH) in Q3 2018, closing a stake of 619,085 shares — an estimated $16.9M sold.

First Manhattan first reported a position in TBPH in Q2 2014 and held it in 17 quarters. The position peaked at $69.9M in Q2 2017. 93 funds tracked by Wall St. Rank hold TBPH as of Q3 2018.

  • First Manhattan reported no remaining Theravance Biopharma position as of Q3 2018 after selling out during the quarter.
  • First Manhattan sold 619,085 Theravance Biopharma shares in Q3 2018, an estimated $16.9M.
  • First Manhattan first reported a position in Theravance Biopharma in Q2 2014 and held it in 17 quarters.
  • First Manhattan's Theravance Biopharma position peaked at $69.9M in Q2 2017.
  • 93 funds tracked by Wall St. Rank held Theravance Biopharma as of Q3 2018.

Based on First Manhattan's 13F filing for Q3 2018, filed 15 Oct 2018.